Directori de persones
Pere Godoy Garcia

Pere Godoy Garcia

Grau: Doctor/a


pere.godoy(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/A-7662-2010

Publicacions

  • Godoy, P; Toledo, D; Casas, I; Colmenares, K; Vilella, A; Prat, A; Mormeneo-Bayo, S; Bartolome, R; Ibarz, M; Dominguez, A

    Documented vaccination as proof of immunity compared to serology in medical students

    HUMAN VACCINES & IMMUNOTHERAPEUTICS 21 2556584-2556584. .

    [doi:10.1080/21645515.2025.2556584]

  • Godoy P; Pardos J; García Cenoz M; Parrón I; Martínez-Baz I; Ferras J; Rius C; Godoy S; Toledo D; Sanz I; Follia N; Miret C; Alsedà M; Plans-Rubió P; Carol M; Bes N; Sala MR; Caylà J; Muñoz-Almagro C; Castilla J; Domínguez A

    Mask wearing by COVID-19 index cases reduces SARS-CoV-2 transmission to household contacts.

    Epidemiology And Infection 153 -. .

    [doi:10.1017/S0950268825100642]

  • Domínguez A; Torner N; Soldevila N; Varela C; Guerrero-Vadillo M; Peñuelas M; Avellón A; Borràs E; Martínez A; Plans P; Pericas C; Rius C; Godoy P

    Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021.

    PLOS ONE 20 -. .

    [doi:10.1371/journal.pone.0332317]

  • Montserrat-Capdevila, J; Castilla, PV; Zaldúa, YC; Alòs, F; Deniel-Rosanas, J; Simonet, P; Olivares-Sanzo, P; Diaz, JJ; Garcia, SM; Fuentes, A; Paredes, E; Godoy, P

    Clinical Characteristics and Risk Factors for Severe Exacerbation in Never-Smokers with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

    Healthcare 13 -. .

    [doi:10.3390/healthcare13182374]

  • Huguet-Feixa, A; Artigues-Barberà, E; Sol, J; Gomez-Arbones, X; Godoy, P; Bravo, MO

    Vaccine refusal and hesitancy in Spain: an online cross-sectional questionnaire

    Bmc Primary Care 26 132-132. .

    [doi:10.1186/s12875-025-02820-2]

  • Godoy, S; Alsedà, M; Parrón, I; Millet, JP; Cayla, JA; Follia, N; Carol, M; Orcau, A; Toledo, D; Ferrus, G; Plans, P; Barrabeig, I; Clotet, L; Domínguez, A; March-Llanes, J; Godoy, P

    Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations

    Pathogens 14 -. .

    [doi:10.3390/pathogens14020175]

  • Huguet-Feixa, A; Ahmed, W; Artigues-Barberà, E; Sol, J; Gomez-Arbones, X; Godoy, P; Bravo, MO

    Mapping Vaccine Sentiment by Analyzing Spanish-Language Social Media Posts and Survey-Based Public Opinion: Dual Methods Study

    Jmir Infodemiology 5 -. .

    [doi:10.2196/63223]

  • Huguet-Feixa, A; Ahmed, W; Artigues-Barberà, E; Sol, J; Godoy, P; Bravo, MO

    Vaccination Conversations on X in Spanish and Catalan: Qualitative Content Analysis

    Jmir Infodemiology 5 -. .

    [doi:10.2196/67942]

  • Domínguez, A; Avellón, A; Hernando, V; Soldevila, N; Borràs, E; Martínez, A; Izquierdo, C; Torner, N; Pericas, C; Rius, C; Godoy, P

    Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination

    Vaccines 12 -. .

    [doi:10.3390/vaccines12111254]

  • Vera-Punzano, N; Bullón-Vela, V; Miret, C; Pardos-Plaza, J; Cenoz, MG; Godoy, P; Castilla, J; Domínguez, A; Toledo, D; Martínez-Baz, I

    Assessment of Long-Term Changes in Knowledge and Attitudes of Household Contacts of COVID-19 Cases in Northern Spain

    Infectious Disease Reports 16 923-931. .

    [doi:10.3390/idr16050074]

  • Plans-Rubió, P; Pericas, C; Avellon, AM; Izquierdo, C; Martínez, A; Torner, N; Martínez, A; Borras, E; Roig, F; Godoy, P; Rius, C

    Healthcare and Epidemiological Surveillance Costs of Hepatitis A Outbreaks in Spain in Regions with and without Universal Hepatitis A Vaccination of Children during 2010-2018

    Vaccines 12 -. .

    [doi:10.3390/vaccines12060648]

  • Dominguez, A; Avellon, A; Hernando, V; Soldevila, N; Borras, E; Martinez, A; Izquierdo, C; Torner, N; Pericas, C; Rius, C; Godoy, P

    Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain

    Vaccines 12 -. .

    [doi:10.3390/vaccines12050488]

Projectes

  • Factores asociados a la transmisión de SARS-CoV-2 en los convivientes de Cataluña y Navarra y efectividad de las vacunas y de las medidas no farmacológicas para reducir la transmisión.
  • Incidencia y factores predictores de tuberculosis y del cumplimiento del tratamiento de la infección tuberculosa latente en una cohorte de expuestos a Mycobacterium tuberculo
  • Estudi del preservatiu en població universitaria a Lleida
  • CHLAMY-01: Detecció de la infecció per Clhamydia Trachomtis en gent jove en un Servei d'Urgències